← Evidence map

ArticleFrontiers in oncology2024

Interleukin-41: a novel serum marker for the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.

Yazhao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38835390